Similar articles

• Treating osteoporosis.

  Smith G, Stassen L, Flint S. Smith G, et al. Ir Med J. 2009 Mar;102(3):88; author reply 89. Ir Med J. 2009. PMID: 19489199 No abstract available.
• [Jaw necrosis following treatment with biphosphonates--the dose is of crucial significance for the risk].

  Langdahl BL, Hitz M, Melsen B, Pinholt EM. Langdahl BL, et al. Ugeskr Laeger. 2009 Mar 23;171(13):1103; author reply 1103. Ugeskr Laeger. 2009. PMID: 19330957 Danish. No abstract available.
• Bisphosphonates and osteonecrosis of the jaws: a primer for physicians for management and risk identification.

  O'Neill PR, Hopeck J. O'Neill PR, et al. Ir Med J. 2008 Mar;101(3):69-70. Ir Med J. 2008. PMID: 18540540 No abstract available.
• Bisphosphonates and osteonecrosis: potential treatment or serious complication?

  Goytia RN, Salama A, Khanuja HS. Goytia RN, et al. Orthop Clin North Am. 2009 Apr;40(2):223-34. doi: 10.1016/j.ocl.2008.12.002. Orthop Clin North Am. 2009. PMID: 19358907 Review.
• Oral bisphosphonates and osteonecrosis of the jaw.

  Wynn RL. Wynn RL. Gen Dent. 2007 Jan-Feb;55(1):8-10. Gen Dent. 2007. PMID: 17333956 Review. No abstract available.